Related Experiment Videos
Strategy of management for congenital biliary dilatation in early infancy
Yasuhiro Ohtsuka1, Hideo Yoshida, Tadashi Matsunaga
1Department of Pediatric Surgery, Graduate School of Medicine, Chiba University, Chiba, Japan.
Insights
Early definitive surgery for congenital biliary dilatation (CBD) before 2 months is recommended. Percutaneous transhepatic cholangiodrainage (PTCD) may be considered for high-risk infants but can lead to complications.
Area of Science:
- Pediatric Surgery
- Gastroenterology
- Congenital Malformations
Background:
- Congenital biliary dilatation (CBD) requires optimal management in early infancy.
- Early diagnosis and intervention are crucial for improving outcomes.
Purpose of the Study:
- To establish the optimal management strategy for congenital biliary dilatation (CBD) in early infancy.
- To compare outcomes of early versus delayed definitive surgery for CBD.
Main Methods:
- Retrospective analysis of 14 infants with CBD treated within 5 months of age.
- Comparison between early definitive surgery (E group) and delayed surgery after PTCD (D group).
Main Results:
- The delayed surgery group (D) had a significantly longer hospital stay.
- Short-term complications included hepatolithiasis (1 patient, E group) and catheter-related issues (3 patients, D group).
- No significant differences in other clinical data or long-term complications were observed.
Conclusions:
- Early definitive surgery with wide anastomosis before 2 months of age is proposed as the standard management for CBD.
- Percutaneous transhepatic cholangiodrainage (PTCD) may be a viable option for extremely poor surgical risk patients under strict conditions.
Purpose:
The aim of this study was to establish the optimal management strategy of congenital biliary dilatation (CBD) in early infancy.
Methods:
Over the last 15 years, 14 patients with CBD in early infancy (within 5 months), including 3 antenatally diagnosed patients, were treated in the authors' department. Of the 14 patients, 7 (50%) underwent early definitive surgery (E group), and the other 7 (50%) underwent delayed primary definitive surgery after percutaneous transhepatic cholangiodrainage (PTCD; D group). Both groups were compared retrospectively using clinical data.
Results:
Pretreatment status and backgrounds of the patients were clinically homogeneous between the 2 groups. The total length of hospital stay was significantly longer in the D group. As short-term complications, 1 patient in the E group was compromised with hepatolithiasis, and 3 patients in the D group were compromised with catheter-related complications. Other clinical data, such as age at definitive surgery, blood loss, pathologic fibrosis of the liver, jaundice-free day, and long-term complications were not significantly different between the 2 groups.
Conclusions:
The authors propose that the standard of management should be early definitive surgery with wide anastomosis before 2 months of age. However, PTCD might be used under strict consideration of indication and careful management for patients with extremely poor surgical risk.